Pregnancy and antiphospholipid antibodies;Grossesse et anticorps antiphospholipides

Presse Medicale

Volumn 37, Issue 11, 2008, Pages 1666-1675

  Le Guern, Véronique ^a   Goffinet, François ^a  

^a Université Paris Descartes ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA2 GLYCOPROTEIN 1; CORTICOSTEROID DERIVATIVE; DALTEPARIN; ENOXAPARIN; FONDAPARINUX; HEPARIN; HEPARIN CALCIUM; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; NADROPARIN; PHOSPHOLIPID ANTIBODY; PLACEBO; PREDNISOLONE;

ANTIPHOSPHOLIPID SYNDROME; CLINICAL TRIAL; FEMALE INFERTILITY; HUMAN; INTRAUTERINE GROWTH RETARDATION; PLACENTA INSUFFICIENCY; PREECLAMPSIA; PREGNANCY; PREMATURE LABOR; PREMATURITY; SHORT SURVEY; SPONTANEOUS ABORTION;

ANIMALS; ANTIBODIES, ANTIPHOSPHOLIPID; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; ASPIRIN; COMPLEMENT ACTIVATION; DISEASE MODELS, ANIMAL; FEMALE; FETAL DEATH; HEPARIN; HUMANS; PLACENTAL INSUFFICIENCY; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREMATURE BIRTH;

EID: 54549115863     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2008.08.001     Document Type: Short Survey

References (56)

1. Soulier J.B.M. Avortements à répétition, thromboses et anticoagulant circulant antiyhromboplastine. Trois observations. Nouv Presse Med 9 (1980) 859-860
2. Pasquali J.L., Poindron V., Korganow A.S., and Martin T. Physiopathologie du syndrome des antiphospholipides. Presse Med 36 4 Pt 2 (2007) 667-673
3. Wu S., and Stephenson M.D. Obstetrical antiphospholipid syndrome. Semin Reprod Med 24 1 (2006) 40-53
4. Levine J.S., Branch D.W., and Rauch J. The antiphospholipid syndrome. N Engl J Med 346 10 (2002) 752-763
5. Tincani A., Spatola L., Cinquini M., Meroni P., Balestrieri G., and Shoenfeld Y. Animal models of antiphospholipid syndrome. Rev Rhum Engl Ed 65 11 (1998) 614-618
6. Sebire N.J., Fox H., Backos M., Rai R., Paterson C., and Regan L. Defective endovascular trophoblast invasion in primary antiphospholipid antibody syndrome-associated early pregnancy failure. Hum Reprod 17 4 (2002) 1067-1071
7. Rand J.H., Wu X.X., Andree H.A., Lockwood C.J., Guller S., Scher J., et al. Pregnancy loss in the antiphospholipid-antibody syndrome-a possible thrombogenic mechanism. N Engl J Med 337 3 (1997) 154-160
8. Di Simone N., Luigi M.P., Marco D., Fiorella D.N., Silvia D., Clara D.M., et al. Pregnancies complicated with antiphospholipid syndrome: the pathogenic mechanism of antiphospholipid antibodies: a review of the literature. Ann N Y Acad Sci 1108 (2007) 505-514
9. Rand J.H., Wu X.X., Guller S., Scher J., Andree H.A., and Lockwood C.J. Antiphospholipid immunoglobulin G antibodies reduce annexin-V levels on syncytiotrophoblast apical membranes and in culture media of placental villi. Am J Obstet Gynecol 177 4 (1997) 918-923
10. Pierangeli S.S., Girardi G., Vega-Ostertag M., Liu X., Espinola R.G., and Salmon J. Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia. Arthritis Rheum 52 7 (2005) 2120-2124
11. Holers V.M., Girardi G., Mo L., Guthridge J.M., Molina H., Pierangeli S.S., et al. Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J Exp Med 195 2 (2002) 211-220
12. Girardi G., Berman J., Redecha P., Spruce L., Thurman J.M., Kraus D., et al. Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J Clin Invest 112 11 (2003) 1644-1654
13. Girardi G., Redecha P., and Salmon J.E. Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nat Med 10 11 (2004) 1222-1226
14. Salmon J.E., and Girardi G. Antiphospholipid antibodies and pregnancy loss: a disorder of inflammation. J Reprod Immunol 77 1 (2008) 51-56
15. Wilson W.A., Gharavi A.E., Koike T., Lockshin M.D., Branch D.W., Piette J.C., et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 42 7 (1999) 1309-1311
16. Miyakis S., Lockshin M.D., Atsumi T., Branch D.W., Brey R.L., Cervera R., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4 2 (2006) 295-306
17. Balasch J., Creus M., Fabregues F., Civico S., Reverter J.C., Carmona F., et al. Antiphospholipid antibodies and the outcome of pregnancy after the first in-vitro fertilization and embryo transfer cycle. Hum Reprod 13 5 (1998) 1180-1183
18. Roussev R.G., Kaider B.D., Price D.E., and Coulam C.B. Laboratory evaluation of women experiencing reproductive failure. Am J Reprod Immunol 35 4 (1996) 415-420
19. Di Simone N., Raschi E., Testoni C., Castellani R., D'Asta M., Shi T., et al. Pathogenic role of anti-beta 2-glycoprotein I antibodies in antiphospholipid associated fetal loss: characterisation of beta 2-glycoprotein I binding to trophoblast cells and functional effects of anti-beta 2-glycoprotein I antibodies in vitro. Ann Rheum Dis 64 3 (2005) 462-467
20. Ruiz-Irastorza G., and Khamashta M.A. Antiphospholipid syndrome in pregnancy. Rheum Dis Clin North Am 33 2 (2007) 287-297 vi
21. Oshiro B.T., Silver R.M., Scott J.R., Yu H., and Branch D.W. Antiphospholipid antibodies and fetal death. Obstet Gynecol 87 4 (1996) 489-493
22. Empson M., Lassere M., Craig J.C., and Scott J.R. Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials. Obstet Gynecol 99 1 (2002) 135-144
23. Branch D.W., Silver R.M., Blackwell J.L., Reading J.C., and Scott J.R. Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet Gynecol 80 4 (1992) 614-620
24. Lima F., Khamashta M.A., Buchanan N.M., Kerslake S., Hunt B.J., and Hughes G.R. A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin Exp Rheumatol 14 2 (1996) 131-136
25. Pauzner R., Dulitzki M., Langevitz P., Livneh A., Kenett R., and Many A. Low molecular weight heparin and warfarin in the treatment of patients with antiphospholipid syndrome during pregnancy. Thromb Haemost 86 6 (2001) 1379-1384
26. Lockshin M.D., Druzin M.L., and Qamar T. Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody. Am J Obstet Gynecol 160 2 (1989) 439-443
27. Caruso A., De Carolis S., Ferrazzani S., Valesini G., Caforio L., and Mancuso S. Pregnancy outcome in relation to uterine artery flow velocity waveforms and clinical characteristics in women with antiphospholipid syndrome. Obstet Gynecol 82 6 (1993) 970-977
28. Huong D.L., Wechsler B., Bletry O., Vauthier-Brouzes D., Lefebvre G., and Piette J.C. A study of 75 pregnancies in patients with antiphospholipid syndrome. J Rheumatol 28 9 (2001) 2025-2030
29. Branch D.W., Porter T.F., Rittenhouse L., Caritis S., Sibai B., Hogg B., et al. Antiphospholipid antibodies in women at risk for preeclampsia. Am J Obstet Gynecol 184 5 (2001) 825-832 discussion 832-834
30. Dreyfus M., Hedelin G., Kutnahorsky R., Lehmann M., Viville B., Langer B., et al. Antiphospholipid antibodies and preeclampsia: a case-control study. Obstet Gynecol 97 1 (2001) 29-34
31. Cowchock F.S., Reece E.A., Balaban D., Branch D.W., and Plouffe L. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol 166 5 (1992) 1318-1323
32. Laskin C.A., Bombardier C., Hannah M.E., Mandel F.P., Ritchie J.W., Farewell V., et al. Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. N Engl J Med 337 3 (1997) 148-153
33. Silver R.K., MacGregor S.N., Sholl J.S., Hobart J.M., Neerhof M.G., and Ragin A. Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients. Am J Obstet Gynecol 169 6 (1993) 1411-1417
34. Triolo G., Ferrante A., Ciccia F., Accardo-Palumbo A., Perino A., Castelli A., et al. Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies. Arthritis Rheum 48 3 (2003) 728-731
35. Branch D.W., Peaceman A.M., Druzin M., Silver R.K., El-Sayed Y., Silver R.M., et al. A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group. Am J Obstet Gynecol 182 1 Pt 1 (2000) 122-127
36. Jeremic K., Pervulov M., Gojnic M., Dukanac J., Ljubic A., and Stojnic J. Comparison of two therapeutic protocols in patients with antiphospholipid antibodies and recurrent miscarriages. Vojnosanit Pregl 62 6 (2005) 435-439
37. Kutteh W.H. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 174 5 (1996) 1584-1589
38. Rai R., Cohen H., Dave M., and Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). Bmj 314 7076 (1997) 253-257
39. Farquharson R.G., Quenby S., and Greaves M. Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstet Gynecol 100 3 (2002) 408-413
40. Carmona F., Font J., Azulay M., Creus M., Fabregues F., Cervera R., et al. Risk factors associated with fetal losses in treated antiphospholipid syndrome pregnancies: a multivariate analysis. Am J Reprod Immunol 46 4 (2001) 274-279
41. Pattison N.S., Chamley L.W., Birdsall M., Zanderigo A.M., Liddell H.S., and McDougall J. Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial. Am J Obstet Gynecol 183 4 (2000) 1008-1012
42. Erkan D., Patel S., Nuzzo M., Gerosa M., Meroni P.L., Tincani A., et al. Management of the controversial aspects of the antiphospholipid syndrome pregnancies: a guide for clinicians and researchers. Rheumatology (Oxford) 47 Suppl 3 (2008) iii23-iii27
43. Derksen R.H., Khamashta M.A., and Branch D.W. Management of the obstetric antiphospholipid syndrome. Arthritis Rheum 50 4 (2004) 1028-1039
44. Cervera R., Piette J.C., Font J., Khamashta M.A., Shoenfeld Y., Camps M.T., et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 46 4 (2002) 1019-1027
45. Empson M., Lassere M., Craig J., and Scott J. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rev 2 (2005) CD002859
46. Stephenson M.D., Ballem P.J., Tsang P., Purkiss S., Ensworth S., Houlihan E., et al. Treatment of antiphospholipid antibody syndrome (APS) in pregnancy: a randomized pilot trial comparing low molecular weight heparin to unfractionated heparin. J Obstet Gynaecol Can 26 8 (2004) 729-734
47. Noble L.S., Kutteh W.H., Lashey N., Franklin R.D., and Herrada J. Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin. Fertil Steril 83 3 (2005) 684-690
48. Wetzl R.G. Anaesthesiological aspects of pregnancy in patients with rheumatic diseases. Lupus 13 9 (2004) 699-702
49. Spitzer K.A., Murphy K., Crowther M., Clark C.A., and Laskin C.A. Postpartum management of women at increased risk of thrombosis-results of a Canadian pilot survey. J Rheumatol 33 11 (2006) 2222-2226
50. Clark C.A., Spitzer K.A., Crowther M.A., Nadler J.N., Laskin M.D., Waks J.A., et al. Incidence of postpartum thrombosis and preterm delivery in women with antiphospholipid antibodies and recurrent pregnancy loss. J Rheumatol 34 5 (2007) 992-996
51. Ginsberg J.S., Greer I., and Hirsh J. Use of antithrombotic agents during pregnancy. Chest 119 1 Suppl (2001) 122S-131S
52. Ostensen M., Khamashta M., Lockshin M., Parke A., Brucato A., Carp H., et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther 8 3 (2006) 209
53. Edwards M.H., Pierangeli S., Liu X., Barker J.H., Anderson G., and Harris E.N. Hydroxychloroquine reverses thrombogenic properties of antiphospholipid antibodies in mice. Circulation 96 12 (1997) 4380-4384
54. Erkan D., Harrison M.J., Levy R., Peterson M., Petri M., Sammaritano L., et al. Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals. Arthritis Rheum 56 7 (2007) 2382-2391
55. Carbillon L., Uzan M., Kettaneh A., Letellier E., Stirnemann J., Perrot N., et al. Preeclampsia and antiphospholipid syndrome. Uterine artery Doppler evaluation. Rev Med Interne 27 2 (2006) 111-116
56. Le Thi Huong D., Wechsler B., Vauthier-Brouzes D., Duhaut P., Costedoat N., Andreu M.R., et al. The second trimester Doppler ultrasound examination is the best predictor of late pregnancy outcome in systemic lupus erythematosus and/or the antiphospholipid syndrome. Rheumatology (Oxford) 45 3 (2006) 332-338